NCT03347318 2026-03-19
PROFILING
Fondazione del Piemonte per l'Oncologia
Active not recruiting
Clinical Trials
72 trialsNCT04897022 2026-03-12
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT03074513 2026-03-11
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04870788 2026-03-11
Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06367751 2026-03-11
LIQPLAT
University Hospital, Basel, Switzerland
Phase NA Active not recruiting
NCT07450560 2026-03-10
Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET
Anhui Provincial Cancer Hospital
Active not recruiting
NCT07461181 2026-03-10
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2 Active not recruiting
NCT02959463 2026-03-06
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02701712 2026-03-05
MRgRT
University Health Network, Toronto
Phase NA Active not recruiting
NCT04028570 2026-03-05
SMARTER
University Health Network, Toronto
Phase NA Active not recruiting
NCT07407985 2026-02-12
GK01IIT-TZ03
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Active not recruiting
NCT05605496 2026-02-10
IMMUNONET
Centre Leon Berard
Phase 2 Active not recruiting
NCT03686202 2026-02-09
MET4-IO
University Health Network, Toronto
Phase 2/3 Active not recruiting
NCT04375228 2026-02-06
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)
Columbia University
Phase 2 Active not recruiting
NCT00639301 2026-02-02
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT05918666 2026-01-30
RATIONAL
Federation of Italian Cooperative Oncology Groups
Active not recruiting
NCT06625619 2026-01-28
On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge
City of Hope Medical Center
Active not recruiting
NCT04733027 2026-01-22
Clever Peptide
Institut Curie
Phase EARLY_PHASE1 Active not recruiting
NCT03269227 2026-01-16
MesoRT
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase NA Active not recruiting
NCT03996265 2026-01-15
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
University of Rochester
Phase 3 Active not recruiting
NCT03875287 2026-01-12
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Active not recruiting
NCT05245682 2026-01-08
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Emory University
Phase EARLY_PHASE1 Active not recruiting
NCT01591356 2026-01-07
EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT02870907 2026-01-07
RB SFCE 09
Institut Curie
Phase 2 Active not recruiting
NCT05868486 2026-01-02
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
City of Hope Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT03599765 2025-12-31
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT02153229 2025-12-26
MPM-PDT
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
NCT05267912 2025-12-16
ORGANOTREAT
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Active not recruiting
NCT07260513 2025-12-03
GH2616C102
Suzhou Genhouse Bio Co., Ltd.
Phase 1 Active not recruiting
NCT03618381 2025-11-20
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Phase 1 Active not recruiting
NCT04483778 2025-11-20
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Phase 1 Active not recruiting
NCT05038839 2025-11-20
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT07236983 2025-11-19
GM&ICI
Fondazione IRCCS Policlinico San Matteo di Pavia
Active not recruiting
NCT05035667 2025-11-03
Patient Considerations of Social Media Account Management After Death
M.D. Anderson Cancer Center
Active not recruiting
NCT01375114 2025-10-28
The Effects of Ginseng on Cancer-Related Fatigue
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT03667378 2025-10-28
Investigating the Impact of Proactive Palliative Care
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT03889795 2025-10-20
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
University of Toledo
Phase 1 Active not recruiting
NCT04989556 2025-10-14
Technology-Enhanced Palliative Care for Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT02414269 2025-10-08
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT03191682 2025-09-25
A First-in-Human Study of PRL3-ZUMAB
National University Hospital, Singapore
Phase 1 Active not recruiting
NCT04409236 2025-09-17
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
Fred Hutchinson Cancer Center
Phase 3 Active not recruiting
NCT04162015 2025-09-12
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT04596384 2025-08-19
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
City of Hope Medical Center
Phase NA Active not recruiting
NCT00715611 2025-08-15
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT03537690 2025-08-12
FID-007 in Treating Participants With Advanced Solid Tumors
University of Southern California
Phase 1 Active not recruiting
NCT02498912 2025-07-31
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT07082257 2025-07-28
Precision Performance Status Compared With ECOG Performance Status
University of Southern California
Active not recruiting
NCT04577326 2025-07-25
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT05275777 2025-07-25
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
National University Hospital, Singapore
Phase 1/2 Active not recruiting
NCT06610227 2025-07-16
A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Active not recruiting